Ofstead & Associates, Inc.
Minimizing the risk of exposure, injury, and infection during bronchoscopy
|Access Date||Quiz Result||Score||Actions|
Eligible for 1.0 contact hour | HSPA | CBSPD | RN |
Numerous outbreaks and patient injuries have been linked to the use of contaminated and damaged bronchoscopes. Residual bioburden in bronchoscopes can also impact clinical lab results and cause patients to be treated for infections they may not have. Bronchoscopes are used and reprocessed by diverse personnel in numerous departments, which makes it challenging to ensure that reprocessing is done correctly every time—especially when bronchoscopes are used in emergency situations. This webinar explores factors that contribute to patient vulnerability and reprocessing effectiveness. The presenter will discuss insights from her research and recommendations for quality management strategies that participants can implement in their own institutions. This course is designed to provide clinicians, perioperative nurses, central service managers, and reprocessing personnel with information and resources that will enable them to evaluate and improve their bronchoscope reprocessing and maintenance programs.
By the end of this one-hour webinar, participants will be able to:
- Discuss the consequences of using damaged or dirty bronchoscopes
- List several factors that increase the risk of complications for bronchoscopy patients
- Describe common challenges encountered during bronchoscope reprocessing
- Explain key findings from real-world studies on bronchoscope reprocessing effectiveness
- Outline five quality assurance strategies for improving safety for bronchoscopy patients
- Patient injuries and infections due to the use of damaged or contaminated bronchoscopes
- The impact of pseudo-outbreaks on laboratory results and patient care
- Basics on bronchoscopes (anatomy, procedural use, characteristics of different types of scopes)
- Factors that increase the risks associated with bronchoscopy
- Guidelines for reprocessing and quality assurance (AORN, AAMI ST91, ACCP/AAB)
- Real world evidence on reprocessing quality and outcomes
- How to assess quality and identify areas for improvement
- What to expect when conducting audits, performing tests for residual soil, and inspecting bronchoscopes using lighted magnification and borescopes
- Strategies for improving the quality of bronchoscope reprocessing and storage
- Sponsor acknowledgement (Supported by an educational grant from Healthmark)
Cori L. Ofstead, MSPH
President & CEO, Ofstead & Associates
Cori L. Ofstead, MSPH, is an epidemiologist with 30 years of experience designing and conducting studies about the impact of clinical processes on patient outcomes. She has served as the Principal Investigator on numerous studies related to infection prevention, instrument reprocessing, and vaccination against infectious diseases. Ms. Ofstead is nationally recognized for her groundbreaking research, and her studies have been published in peer-reviewed journals including CHEST, AJIC, ICHE, Journal of Hospital Infection, Gastroenterology Nursing, and Vaccine. She currently serves as a reviewer for AJIC, Endoscopy, and the Journal of Urology, and is an active member of the editorial board for AJIC. She has presented the findings of her studies at national and international conferences sponsored by the CDC, APIC, IAHCSMM, AORN, SGNA, AGA, and several universities. In addition, she currently serves as a preceptor for epidemiology students in the School of Public Health at the University of Minnesota.